📢oxaliplatin-based HIPEC resulted in superior overall and recurrence-free survival compared to mitomycin C-based HIPEC in patients with peritoneal metastasized colorectal cancer undergoing cytoreductive surgery. BJS Open OncoAlert Cihangir Akyol, MD Erman Akkus